AT238716B - Verfahren zur Herstellung von neuen Derivaten des 7-Oxycumarins - Google Patents

Verfahren zur Herstellung von neuen Derivaten des 7-Oxycumarins

Info

Publication number
AT238716B
AT238716B AT649162A AT649162A AT238716B AT 238716 B AT238716 B AT 238716B AT 649162 A AT649162 A AT 649162A AT 649162 A AT649162 A AT 649162A AT 238716 B AT238716 B AT 238716B
Authority
AT
Austria
Prior art keywords
oxycoumarin
preparation
new derivatives
derivatives
new
Prior art date
Application number
AT649162A
Other languages
German (de)
English (en)
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DEC24871A external-priority patent/DE1186078B/de
Priority claimed from DEC25468A external-priority patent/DE1210883B/de
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Application granted granted Critical
Publication of AT238716B publication Critical patent/AT238716B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT649162A 1961-08-12 1962-08-10 Verfahren zur Herstellung von neuen Derivaten des 7-Oxycumarins AT238716B (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEC24871A DE1186078B (de) 1961-08-12 1961-08-12 Verfahren zur Herstellung von Derivaten des 7-Oxy-cumarins
DEC25468A DE1210883B (de) 1961-11-09 1961-11-09 Verfahren zur Herstellung von Derivaten des 7-Oxycumarins
DEC0026091 1962-01-26
DEC0026092 1962-01-26

Publications (1)

Publication Number Publication Date
AT238716B true AT238716B (de) 1965-02-25

Family

ID=27436691

Family Applications (1)

Application Number Title Priority Date Filing Date
AT649162A AT238716B (de) 1961-08-12 1962-08-10 Verfahren zur Herstellung von neuen Derivaten des 7-Oxycumarins

Country Status (8)

Country Link
US (1) US3282938A (cs)
AT (1) AT238716B (cs)
CH (1) CH415676A (cs)
DK (1) DK105069C (cs)
FR (1) FR1332328A (cs)
GB (1) GB1014053A (cs)
NL (2) NL6514403A (cs)
SE (1) SE303508B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1259349B (de) * 1964-10-17 1968-01-25 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Derivaten des 7-Oxycumarins
US3515721A (en) * 1967-06-26 1970-06-02 Cassella Farbwerke Mainkur Ag 3-tertiary-aminoethyl-4-methyl or phenyl-7-ethoxycarbonylmethoxy - halo or mononitro coumarins and congeners
US3625976A (en) * 1969-12-09 1971-12-07 Int Flavors & Fragrances Inc Coumarin ether sun-screening compounds
US3859311A (en) * 1972-02-25 1975-01-07 Universal Oil Prod Co Preparation of coumarins
IT1160365B (it) * 1978-12-19 1987-03-11 F I D I A Spa Applicazioni in campo farmacologico e terapeutico dell'8-cloro-3-(beta-dietilamincetil)-4-metil-7-etossi-carbonilmetossicumarina cloridrato preparato allo stato puro mediante procedimento selettivo, con particolare riguardo alla sua azione antiaritmica
US5247099A (en) * 1989-08-17 1993-09-21 Abbott Laboratories Process for synthesis of 7-hydroxy coumarins having substitutions in the 4-position
IT1247476B (it) * 1991-06-14 1994-12-17 Fidia Spa Derivati della cumarina.
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
KR100638399B1 (ko) 2005-06-09 2006-10-25 한국화학연구원 4-히드록시쿠마린 유사체의 제조방법
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2559319T3 (es) 2007-06-04 2016-02-11 Synergy Pharmaceuticals Inc. Agonistas de guanilato cliclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
WO2009149279A2 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN104603121B (zh) 2012-07-27 2018-06-26 太阳化学公司 作为油墨中的光引发剂和光敏剂的香豆素酮
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治疗胃肠道病症的组成物
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US10703735B2 (en) * 2018-07-25 2020-07-07 Lead Discovery Center Gmbh 4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer
PL3911648T3 (pl) 2019-01-18 2025-03-10 Astrazeneca Ab 6'-[[(1s,3s)-3-[[5-(difluorometoksy)-2- pirymidynylo]amino]cyklopentylo]amino][1(2h),3'-bipirydyn]-2-on jako inhibitor pcsk9 i sposoby jego zastosowania

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2498497A (en) * 1949-06-10 1950-02-21 Sterling Drug Inc 2[2(phthalimido)ethyl]pyridines
NL88205C (cs) * 1954-02-08
US2980673A (en) * 1954-10-14 1961-04-18 Cutter Lab Bis-quaternary ammonium esters of amino-carboxylic acids and aminoalcohols
US2844591A (en) * 1955-10-14 1958-07-22 Mead Johnson & Co 1-substituted-3-pyrrolidylmethyl benzilates and salts thereof
US3074953A (en) * 1962-01-17 1963-01-22 American Home Prod 5-(3'-(4-phenyl-4-carbethoxy piperidino)-propylidene) dibenzo (a,d) (1,4) cycloheptadiene

Also Published As

Publication number Publication date
NL281975A (cs)
SE303508B (cs) 1968-09-02
DK105069C (da) 1966-08-15
CH415676A (de) 1966-06-30
US3282938A (en) 1966-11-01
GB1014053A (en) 1965-12-22
NL6514403A (cs) 1966-01-25
FR1332328A (fr) 1963-07-12

Similar Documents

Publication Publication Date Title
AT238716B (de) Verfahren zur Herstellung von neuen Derivaten des 7-Oxycumarins
AT239788B (de) Verfahren zur Herstellung von neuen β-Carbolin-carbonsäureamid-Derivaten
CH426859A (de) Verfahren zur Herstellung von neuen Dihalogen-amino-benzylaminen
AT243798B (de) Verfahren zur Herstellung von neuen 4-Aminochinolinderivaten
CH448074A (de) Verfahren zur Herstellung von neuen 19-Hydroxysteroiden
AT242141B (de) Verfahren zur Herstellung von neuen Derivaten des 4-Aminochinolins
AT230894B (de) Verfahren zur Herstellung von neuen Pyridazinderivaten
AT244977B (de) Verfahren zur Herstellung von neuen Oxazinderivaten
CH385852A (de) Verfahren zur Herstellung von neuen Iminodibenzylderivaten
CH415674A (de) Verfahren zur Herstellung von Derivaten des 3-Phenyl-7-oxychromons
CH438265A (de) Verfahren zur Herstellung von neuen Azidobenzolsulfonylharnstoffen
CH386428A (de) Verfahren zur Herstellung von neuen Iminodibenzylderivaten
CH407120A (de) Verfahren zur Herstellung von neuen Piperidinderivaten
AT241473B (de) Verfahren zur Herstellung von neuen 1-Azathiaxanthenderivaten
CH441339A (de) Verfahren zur Herstellung von neuen Oxopyrimidinen
CH464946A (de) Verfahren zur Herstellung von neuen Derivaten des 6-Methyl-und 1,6-Dimethyl-ergolins II
AT250572B (de) Verfahren zur Herstellung von neuen Heptapeptidderivaten
CH428744A (de) Verfahren zur Herstellung von neuen 5-Phenylcytosinderivaten
CH414040A (de) Verfahren zur Herstellung von neuen Derivaten der Dianthronäthylene
AT239796B (de) Verfahren zur Herstellung von neuen Benzolsulfonyl-alkylen-semicarbaziden
AT248626B (de) Verfahren zur Herstellung von neuen 19-Hydroxysteroiden
AT245573B (de) Verfahren zur Herstellung von neuen Derivaten des Sulfanilamidopyrimidins
AT240533B (de) Verfahren zur Herstellung von neuen Derivaten des Schizozygins
CH376507A (de) Verfahren zur Herstellung von neuen Pyrrolidylmethyl-phenothiazinen
CH427799A (de) Verfahren zur Herstellung von neuen Benzolsulfonylsemicarbaziden